Literature DB >> 30108544

Neuroprotective Effect of Artesunate in Experimental Model of Traumatic Brain Injury.

Enrico Gugliandolo1, Ramona D'Amico1, Marika Cordaro1, Roberta Fusco1, Rosalba Siracusa1, Rosalia Crupi1, Daniela Impellizzeri1, Salvatore Cuzzocrea1,2, Rosanna Di Paola1.   

Abstract

Traumatic brain injuries (TBI) are an important public health challenge. In addition, subsequent events at TBI can compromise the quality of life of these patients. In fact, TBI is associated with several complications for both long and short term, some evidence shows how TBI is associated with a decline in cognitive functions such as the risk of developing dementia, cerebral atrophy, and Parkinson disease. After the direct damage from TBI, a key role in TBI injury is played by the inflammatory response and oxidative stress, that contributes to tissue damage and to neurodegenerative processes, typical of secondary injury, after TBI. Given the complex series of events that are involved after TBI injury, a multitarget pharmacological approach is needed. Artesunate is a more stable derivative of its precursor artemisin, a sesquiterpene lactone obtained from a Chinese plant Artemisia annua, a plant used for centuries in traditional Chinese medicine. artesunate has been shown to be a pluripotent agent with different pharmacological actions. therefore, in this experimental model of TBI we evaluated whether the treatment with artesunate at the dose of 30 mg\Kg, had an efficacy in reducing the neuroinflammatory process after TBI injury, and in inhibiting the NLRP3 inflammasome pathway, which plays a key role in the inflammatory process. We also assessed whether treatment with artesunate was able to exert a neuroprotective action by modulating the release of neurotrophic factors. our results show that artesunate was able to reduce the TBI-induced lesion, it also showed an anti-inflammatory action through the inhibition of Nf-kb, release of proinflammatory cytokines IL-1β and TNF-α and through the inhibition NLRP3 inflammasome complex, furthermore was able to reduce the activation of astrocytes and microglia (GFAP, Iba-1). Finally, our results show that the protective effects of artesunate also occur through the modulation of neurotrophic factors (BDNF, GDNF, NT-3) that play a key role in neuronal survival.

Entities:  

Keywords:  artemisin; artesunate; neurodegeneration; neuroinflammation; traumatic brain injury

Year:  2018        PMID: 30108544      PMCID: PMC6079305          DOI: 10.3389/fneur.2018.00590

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  59 in total

Review 1.  Initiation and perpetuation of NLRP3 inflammasome activation and assembly.

Authors:  Eric I Elliott; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 2.  Artesunate for the treatment of severe falciparum malaria.

Authors:  Philip J Rosenthal
Journal:  N Engl J Med       Date:  2008-04-24       Impact factor: 91.245

3.  Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.

Authors:  L Clemmer; Y C Martins; G M Zanini; J A Frangos; L J M Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

4.  Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis.

Authors:  Dejiang Zhou; Eliezer Masliah; Stephen A Spector
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

5.  Combination therapy with melatonin and dexamethasone in a mouse model of traumatic brain injury.

Authors:  Michela Campolo; Akbar Ahmad; Rosalia Crupi; Daniela Impellizzeri; Rossana Morabito; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  J Endocrinol       Date:  2013-04-29       Impact factor: 4.286

6.  Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals.

Authors:  David Patsouris; Ping-Ping Li; Divya Thapar; Justin Chapman; Jerrold M Olefsky; Jaap G Neels
Journal:  Cell Metab       Date:  2008-10       Impact factor: 27.287

7.  Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury.

Authors:  Lamin H A N Mbye; Indrapal N Singh; Kimberly M Carrico; Kathryn E Saatman; Edward D Hall
Journal:  J Cereb Blood Flow Metab       Date:  2008-08-20       Impact factor: 6.200

Review 8.  Modulation of immune response by head injury.

Authors:  Maria Cristina Morganti-Kossmann; Laveniya Satgunaseelan; Nicole Bye; Thomas Kossmann
Journal:  Injury       Date:  2007-11-28       Impact factor: 2.586

9.  Association between long-term cognitive decline in Vietnam veterans with TBI and caregiver attachment style.

Authors:  Andrea Brioschi Guevara; Jean-François Démonet; Elena Polejaeva; Kristine M Knutson; Eric M Wassermann; Frank Krueger; Jordan Grafman
Journal:  J Head Trauma Rehabil       Date:  2015 Jan-Feb       Impact factor: 2.710

10.  Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium.

Authors:  Irina Alafuzoff; Thomas Arzberger; Safa Al-Sarraj; Istvan Bodi; Nenad Bogdanovic; Heiko Braak; Orso Bugiani; Kelly Del-Tredici; Isidro Ferrer; Ellen Gelpi; Giorgio Giaccone; Manuel B Graeber; Paul Ince; Wouter Kamphorst; Andrew King; Penelope Korkolopoulou; Gábor G Kovács; Sergey Larionov; David Meyronet; Camelia Monoranu; Piero Parchi; Efstratios Patsouris; Wolfgang Roggendorf; Danielle Seilhean; Fabrizio Tagliavini; Christine Stadelmann; Nathalie Streichenberger; Dietmar R Thal; Stephen B Wharton; Hans Kretzschmar
Journal:  Brain Pathol       Date:  2008-03-26       Impact factor: 6.508

View more
  24 in total

1.  Role of Etanercept and Infliximab on Nociceptive Changes Induced by the Experimental Model of Fibromyalgia.

Authors:  Marika Cordaro; Rosalba Siracusa; Ramona D'Amico; Tiziana Genovese; Gianluca Franco; Ylenia Marino; Davide Di Paola; Salvatore Cuzzocrea; Daniela Impellizzeri; Rosanna Di Paola; Roberta Fusco
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

Review 2.  Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives.

Authors:  Boshi Huang; Yan Zhang
Journal:  Drug Discov Today       Date:  2022-02-16       Impact factor: 8.369

3.  The Effect of Rutin on Experimental Traumatic Brain Injury and Edema in Rats.

Authors:  Sahin Yuceli; Gulce Naz Yazici; Renad Mammadov; Halis Suleyman; Mustafa Kaya; Selcuk Ozdogan
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 4.  Aging Neurovascular Unit and Potential Role of DNA Damage and Repair in Combating Vascular and Neurodegenerative Disorders.

Authors:  Yan Li; Lv Xie; Tingting Huang; Yueman Zhang; Jie Zhou; Bo Qi; Xin Wang; Zengai Chen; Peiying Li
Journal:  Front Neurosci       Date:  2019-08-08       Impact factor: 4.677

5.  Artesunate attenuates traumatic brain injury-induced impairments in rats.

Authors:  Zhike Zhou; Jun Hou; Qinghua Li
Journal:  Transl Neurosci       Date:  2020-09-09       Impact factor: 1.757

6.  NLRP3 Inflammasome: A New Pharmacological Target for Reducing Testicular Damage Associated with Varicocele.

Authors:  Pietro Antonuccio; Antonio Girolamo Micali; Carmelo Romeo; Jose Freni; Giovanna Vermiglio; Domenico Puzzolo; Francesco Squadrito; Natasha Irrera; Herbert R Marini; Rosa Alba Rana; Giovanni Pallio; Letteria Minutoli
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 6.208

7.  Artesunate Suppresses the Proliferation and Development of Estrogen Receptor-α-Positive Endometrial Cancer in HAND2-Dependent Pathway.

Authors:  Xianghua Yin; Yan Liu; Jiarui Qin; Yixuan Wu; Jiayan Huang; Qi Zhao; Tingting Dang; Yacui Tian; Ping Yu; Xiyue Huang
Journal:  Front Cell Dev Biol       Date:  2021-01-12

8.  Hidrox® Roles in Neuroprotection: Biochemical Links between Traumatic Brain Injury and Alzheimer's Disease.

Authors:  Marika Cordaro; Angela Trovato Salinaro; Rosalba Siracusa; Ramona D'Amico; Daniela Impellizzeri; Maria Scuto; Maria Laura Ontario; Roberto Crea; Salvatore Cuzzocrea; Rosanna Di Paola; Roberta Fusco; Vittorio Calabrese
Journal:  Antioxidants (Basel)       Date:  2021-05-20

9.  Regulation of Inflammatory and Proliferative Pathways by Fotemustine and Dexamethasone in Endometriosis.

Authors:  Tiziana Genovese; Rosalba Siracusa; Ramona D'Amico; Marika Cordaro; Alessio Filippo Peritore; Enrico Gugliandolo; Rosalia Crupi; Angela Trovato Salinaro; Emanuela Raffone; Daniela Impellizzeri; Salvatore Cuzzocrea; Roberta Fusco; Rosanna Di Paola
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

10.  Effect of Artesunate on Leishmania Amazonesis Induced Neuroinflammation and Nociceptive Behavior in Male Balb/C Mice.

Authors:  Enrico Gugliandolo; Ernesto Palma; Alessio Filippo Peritore; Rosalba Siracusa; Ramona D'Amico; Roberta Fusco; Patrizia Licata; Rosalia Crupi
Journal:  Animals (Basel)       Date:  2020-03-27       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.